EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseStudienprotokollOpen Access

A Higher-Than-Standard-Intensity International Normalized Ratio Goal for Patients Undergoing Mechanical Aortic Valve Replacement With Additional Thrombotic Risk Factors: Protocol for a Systematic Review and Meta-Analysis

Myung-Rho Kim iD, Taha Shaikh iD, Shawn Wang iD, Spencer Taylor iD, Vidhani Goel iD, Banveet Kaur Khetarpal iD, Chowdhury Ahsan iD, Kavita Batra iD

JMIR Research Protocols · 2025

DOI: 10.2196/73389 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Myung-Rho Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, United States. Hauptthemen laut MEDLINE: International Normalized Ratio, Thrombosis, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lifelong anticoagulation therapy with vitamin K antagonists is recommended following mechanical aortic valve replacement (MAVR) to prevent valve thrombosis. Current guidelines recommend a standard international normalized ratio (INR) of 2.5 for patients with MAVR without additional thromboembolic risk factors, and a higher INR goal of 3.0 for those with conditions such as atrial fibrillation, prior thromboembolism, or left ventricular dysfunction. However, limited clinical evidence exists to guide anticoagulation intensity in this high-risk subgroup, necessitating a systematic review.

Objective

We aimed to assess the safety and efficacy of higher-intensity INR goals (>3.0) compared to standard-intensity goals (approximately 2.5) in patients with MAVR with additional thromboembolic risk factors.

Methods

This protocol describes a systematic review and meta-analysis following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. A comprehensive literature search will be conducted across PubMed, Embase, and the Cochrane Library for studies published before December 18, 2024. Eligible studies include randomized controlled trials (RCTs), cohort studies, and follow-up studies involving adult patients with MAVR on warfarin therapy, stratified by the presence of additional thromboembolic risk factors. Non–English-language studies, case reports, editorials, and animal studies will be excluded.

Results

The review will synthesize existing data to compare the risks and benefits of intensified anticoagulation in patients with MAVR with additional thromboembolic risk factors. Data analysis and manuscript preparation are scheduled for July-August 2025.

Conclusions

This study will provide critical evidence on INR management in high-risk patients with MAVR, potentially informing future updates to clinical guidelines and optimizing the balance between thromboembolic prevention and bleeding risk. International Registered Report Identifier (IRRID) PRR1-10.2196/73389

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

International Normalized RatioThrombosisHeart Valve Prosthesis ImplantationAortic ValveHeart Valve ProsthesisHumansSystematic Reviews as TopicRisk FactorsMeta-Analysis as TopicAnticoagulantsWarfarinThromboembolism

Stichwörter der Autor:innen

CoumadinMAVRanticoagulationinternational normalized ratiomechanical aortic valve replacementthromboembolic risk factorsthromboembolismvitamin K antagonistwarfarin

Substanzen

AnticoagulantsWarfarin

Autor:innen und Institutionen

  • Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, United States.
  • Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, United States.
  • School of Public Health, University of Nevada, Las Vegas, Las Vegas, NV, United States.
  • Division of Cardiovascular Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, United States.
  • Office of Research and Department of Medical Education, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, United States.

ORCID-Profile: Myung-Rho Kim, Taha Shaikh, Shawn Wang, Spencer Taylor, Vidhani Goel, Banveet Kaur Khetarpal, Chowdhury Ahsan, Kavita Batra

Zitieren

APA

Kim, M. R., Shaikh, T., Wang, S., Taylor, S., Goel, V., Khetarpal, B. K., Ahsan, C., & Batra, K. (2025). A Higher-Than-Standard-Intensity International Normalized Ratio Goal for Patients Undergoing Mechanical Aortic Valve Replacement With Additional Thrombotic Risk Factors: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols. https://doi.org/10.2196/73389

Vancouver

Kim MR, Shaikh T, Wang S, Taylor S, Goel V, Khetarpal BK, et al. A Higher-Than-Standard-Intensity International Normalized Ratio Goal for Patients Undergoing Mechanical Aortic Valve Replacement With Additional Thrombotic Risk Factors: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols. 2025. doi:10.2196/73389

BibTeX
@article{Kim2025,
  author = {Kim, Myung-Rho and Shaikh, Taha and Wang, Shawn and Taylor, Spencer and Goel, Vidhani and Khetarpal, Banveet Kaur and Ahsan, Chowdhury and Batra, Kavita},
  title = {A Higher-Than-Standard-Intensity International Normalized Ratio Goal for Patients Undergoing Mechanical Aortic Valve Replacement With Additional Thrombotic Risk Factors: Protocol for a Systematic Review and Meta-Analysis},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/73389}
}
Kostenlos starten →